Platelet mediated complement activation

Advances in Experimental Medicine and Biology

Volumn 632, Issue , 2008, Pages 81-91

  Peerschke, Ellinor I B ^a   Yin, Wei ^b   Ghebrehiwet, Berhane ^c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Oklahoma State University   (United States)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROSIS; BLOOD VESSEL INJURY; COMPLEMENT ACTIVATION; HEMOSTASIS; HUMAN; INFLAMMATION; NONHUMAN; PATHOPHYSIOLOGY; PLATELET MICROPARTICLE; PRIORITY JOURNAL; REVIEW; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOSIS; ANIMAL; BIOLOGICAL MODEL; BLOOD; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; PHYSIOLOGY; THROMBOCYTE COUNT;

ANIMALS; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; BLOOD PLATELETS; COMPLEMENT ACTIVATION; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL; PLATELET COUNT; THROMBOSIS;

EID: 58149336976     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-78952-1_7     Document Type: Review

References (62)

1. Acostan, J., Qin, X., and Halperin, J. (2004) Complement and complement regulatory proteins as potential molecular targets for vascular diseases. Curr. Pharm. Dis. 10, 203- 211
2. Allegretti, M., Moriconi A., Beccari, A.R., Di Bitondo, R., Bizzarri, C., Bertini, R., and Colotta, F. (2005) Targeting C5a: recent advances in drug discover. Curr. Med. Chem. 12, 217-236
3. Arumugam, T.V., Shields, I.A., Woodruff, T.M., Granger, D.N., and Taylor, S.M. (2004) The role of the complement system in ischemia-reperfusion injury. Shock 21, 401-409
4. Barry, O.P., Pratico, D., Savani, R.C., and FitzGerald, G.A. (1998) Modulation of monocyteendothelial cell interactions by platelet microparticles. J. Clin. Invest.102, 136-144
5. Buerke, M., Prufer, D., Dahm, M., Oelert, H., Meyer, J., and Darius, H. (1998) Blocking of classical complement pathway inhibits endothelial adhesion molecules expression and preserves ischemic myocardium from reperfusion injury. J. Pharmacol. Exp. Ther. 286, 429-438
6. Davis III, A.D. and Kenney, D.M. (1979) Properdin factor D; effects on thrombin-induced platelet aggregation. J. Clin. Invest. 64, 721-728
7. Dedio, J., Jahnen-Dechent, W., Bachmann, M., and Muller-Esterl, W. (1998) The multiligand binding protein gC1qR, putative C1q receptor, is a mitochondrial protein. J. Immunol. 160, 3534-3542
8. Del Conde, I., Cruz, M.A., Zhang, H., Lopez, J.A., and Afshar-Kharghan, V. (2005) Platelet activation leads to activation and propagation of the complement system. J. Exp. Med. 201, 871-879
9. Devine, D.V. and Rosse, W.F. (1987) Regulation of the activity of platelet-bound C3 convertase of the alternative pathway of complement by platelet factor H. Proc. Natl. Acad. Sci. USA 84, 5873-5877
10. Gawaz, M., Ott, I., Reininger, A.J., Heinzmann, U., and Neumann, F.J. (1996) Agglutination of isolated platelet membranes. Arterioscler. Thromb. Vasc. Biol. 16, 621-627
11. George, J.N., Pickett, E.B., Saucerman, S., McEver, R.P., Kunicki, T.J., Kieffer, N., and Newman, P.J. (1986) Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. J. Clin. Invest. 78, 340-348
12. Ghebrehiwet, B. and Peerschke, E.I.B. (1998) Structure and function of gC1qR a multiligand binding membrane protein. Immunobiology 199, 225-238
13. Ghebrehiwet, B., Lim, B.L., Peerschke, E.I.B., Willis, A.C., and Reid, K.B.M. (1994) Isolation of cDNA cloning, and overexpression of a 33-kDa cell surface glycoprotein that binds to the globular heads of C1q. J. Exp. Med. 179, 1809-1821
14. Ghebrehiwet, B., Lim, B.L., Kumar, R., Feng, X., and Peerschke, E.I.B. (2001) gC1qR/p33 a member of a new class of multifunctional and multicompartmental cellular proteins, is involved in inflammation and infection. Immunol. Rev. 180, 65-77
15. Ghebrehiwet, B., Cebada Mora, C., Tantral, L., Jesty, J., and Peerschke, E.I.B. (2006) gC1qR/p33 serves as a molecular bridge between the complement and contact activation systems and is an important catalyst in inflammation. Adv. Exp. Med. Biol. 586, 95-105
16. Giannakopoulos, B., Passam, F., Rahgozar, S., and Krillis, S.A. (2007) Current concepts on the pathogenesis of the antiphospholipid syndrome. Blood 109, 422-430
17. Gnatenko, D.V., Dunn, J.J., McCorkle, S.R., Weissmann, D., Perrotta, P.L., and Bahou, W.E. (2003) Transcript profiling of human platelets using microarray and serial analysis of gene expression. Blood 101, 2285-2293
18. Huber-Lang, M., Sarma, J.V., Zetoune, F.S., Rittirsch, D., Neff, T.A., McGuire, S.R., Lambris, J.D., Warner, R.L., Flierl, M.A., Hoesel, L.M., Gebhard, F., Younger, J.G., Drouin, S.M., Wetsel, R.A., and Ward, P.A. (2006) Generation of C5a in the absence of C3: a new complement activation pathway. Nat. Med. 12, 682-687
19. Ikeda, K., Nagasawa, K., Horiuchi, T., Nishizaka, H., and Niho, Y. (1997) C5a induced tissue factor activity on endothelial cells. Thromb. Haemost. 77, 394-398
20. Jiang, J., Zhang, Y., Krainer, A., and Xu, R.M. (1999) Crystal structure of p32, a doughnutshaped acidic mitochondrial matrix protein. Proc. Natl. Acad. Sci. U S A 96, 3572-3577
21. Kansas, G.S. (1996) Selectins and their ligands: current concepts and controversies. Blood 88, 3259-3287
22. Kaplan, A.P., Silverberg, M., and Ghebrehiwet, B. (1986) The intrinsic coagulation/kinin pathway - the classical complement pathway and their interactions. Adv. Exp. Med. Biol. 198, 1311-1325
23. Kovacsovics, T., Tschopp, J., Kress, A., and Isliker, H. (1985) Antibody independent activation of C1, the first component of complement by cardiolipin. J. Immunol. 135, 2695-2700
24. Laine, P., Pentikainen, M.O., Wurzner, R., Penttila, A., Paavonen, T., Meri, S., and Kovanen, P.T. (2002) Evidence for complement activation in ruptured coronary plaques in acute myocardial infarction. Am. J. Cardiol. 90, 404-408
25. Mack, W.J., Sughrue, M.W., Ducruet, A.F., Mocco, J., Sosunov, S.A., Hassid, B.G., Silverberg, J.Z., Ten, V.S., Pinsky, D.J., and Connolly Jr., E.S. (2006). Temporal pattern of C1q deposition after transient focal cerebral ischemia. Wiley InterScience (www.interscience.wiley.com) doi:10, 1002/jnr.20775
26. Mahdi, F., Mader, Z.S., Figueroa, C.D., and Schmaier, A.H. (2002) Factor XII interacts with multiprotein assembly of urokinase plasminogen activator receptor, gC1qR and cytokeratin 1 on endothelial cell membranes. Blood 15, 3585-3596
27. Makrides, S.C. (1998) Therapeutic inhibition of the complement system. Pharmacol. Rev. 150, 59-87
28. Markiewski, M.M. and Lambris, J.D. (2007) The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am. J. Pathol. 171, 715-727
29. Markiewski, M.M., Nilsson, B., Ekdahl, K.N., Mollnes, T.E., and Lambris, J.D. (2007) Complement and coagulation: strangers or partners in crime? Trends Immunol. 28, 184- 192
30. Martinez, M.C., Tesse, A., Zobairi, F., and Andriantsitohaina, R. (2005) Shed membrane microparticles from circulating and vascular cells in regulating vascular function. Am. J. Physiol. Heart Circ. Physiol. 288, H1004-H1009
31. Mause, S.F., von Hundelshausen, P., Zernecke, A., Koenen, R.R., and Weber, C. (2005) Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arteriscler. Thromb. Vasc. Biol. 25, 1512-1518
32. Mevorach, D., Mascarenhas, J.O., Gershoev, D., and Eldon, K.B. (1998) Complement dependent clearance of apoptotic cells by human macrophages. J. Exp. Med. 188, 2313- 2320
33. Monsinjon, T., Gasque, P., Chan, P., Ischenko, A., Brady, J.J., and Fontaine, M.C. (2003) Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells. FASEB J. 17, 1003-1014 90
34. Morel, O., Toti, F., Hugel, B., and Freyssinet, J.M. (2004) Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Curr. Opin. Hematol. 11, 156-164
35. Muhlfelder, T.W., Miemetz, J., Kreutzer, D., Beebe, D., Ward, P.A., and Rosenfeld, S.I.(1979) C5 chemotactic fragment induces leukocyte production of tissue factor activity: a link between complement and coagulation. J. Clin. Invest. 63, 147-150
36. Navratil, J.S., Manzi, S., Kao, A.H., Krishnaswami, S., Liu, C.C., Ruffing, M.J., Shaw, P.S., Nilson, A.C., Dryden, E.R., Johnson, J.J., and Ahearn, J.M. (2006). Platelet C4d is highly specific for systemic lupus erythematosus. Arthritis and Rheum. 54, 670-674
37. Niculescu, F., Niculescu, T., and Rus, H. (2004) C5b-9 terminal complement complex assembly on apoptotic cells in human arterial wall with atherosclerosis. Mol. Immunol. 36, 949-955
38. Niculescu, F., and Rus, H. (1999) Complement activation and atherosclerosis. Mol. Immunol. 36, 949-955
39. Patel, S., Thelander, E.M., Hernandez, M., Montenegro, J., Hassing, H., Burton, C., Mundt, S., Hermanowski-Vosatka, A., Wright, S.D., Chao, Y.S., and Detmers, P.A. (2001) ApoE-/- mice develop atherosclerosis in the absence of complement component C5. Biochem. Biophys. Res. Commun. 286, 164-170
40. Peerschke, E.I., and Ghebrehiwet, B. (1997) C1q augments platelet activation in response to aggregated Ig. J. Immunol. 159, 5594-5598
41. Peerschke, E.I.B., Reid, K.B.M., and Ghebrehiwet, B. (1993) Platelet activation by C1q results in the induction of alpha IIb/beta 3 integrins (GPIIb/IIIa) and the expression of P-selectin and procoagulant activity. J. Exp. Med. 178, 579-587
42. Peerschke, E.I.B., Reid, K.B.M., and Ghebrehiwet, B. (1994) Identification of a novel 33- kDa C1q-binding site on human blood platelets. J. Immunol. 152, 5896-5901
43. Peerschke, E.I.B., Murphy, T.K., and Ghebrehiwet, B. (2003) Activation-dependent surface expression of gC1qR/p33 on human blood platelets. Thromb. Haemost. 90, 331-339
44. Peerschke, E.I.B., Petrovan, R.J., Ghebrehiwet, B., and Ruf, W. (2004) Tissue factor pathway inhibitor-2 (TFPI-2) recognizes the complement and kininogen binding protein gC1qR/p33 (gC1qR): implications for vascular inflammation. Thromb. Haemost. 92, 811-819
45. Peerschke, E.I.B., Yin, W., Grigg, S.E., and Ghebrehiwet, B. (2006) Blood platelets activate the classical pathway of human complement. J Thromb Haemost 4, 2035-2042
46. Peerschke, E.I.B., Yin, W., Alpert, D.R., Salmon, J.E., Roubey, R.A.S., and Ghebrehiwet, B. (2007). Enhanced serum complement activation on platelets is associated with arterial thrombosis in patients with systemic lupus erythematosus (SLE) and antiphospholipid antibodies (aPL) (abstract). Blood 110, 488a
47. Perez-Pujol, S., Marker, P.H., and Key, N.S. (2007) Platelet microparticles are heterogeneous and highly dependent on the activation mechanism: studies using a new digital flow cytometer. Cytometry 71A, 38-45
48. Polley, M.J., and Nachman, R.L. (1978) The human complement system in thrombinmediated platelet function. J. Exp. Med. 147, 1713-1726
49. Polley, M.J., and Nachman, R.L. (1979) Human complement in thrombin-mediated platelet function: uptake of the C5b-9 complex. J. Exp. Med. 150, 633-645
50. Polley, M.J., and Nachman, R.L. (1983) Human platelet activation by C3a and C3a des-arg. J. Exp. Med. 158, 603-615
51. Schaiff, W.T., and Eisenberg, P.R. (1997) Direct induction of complement activation by pharmacologic activation of plasminogen. Coron. Artery Dis. 8, 9-18
52. Schmaier, A.H., Amenta, S., Xiong, T., Heda, G.D., and Gewirtz, A.M. (1993) Expression of C1 Inhibitor. Blood 82, 465-474
53. Seidl, W.S., Exner, M., Amighi, J., Kastl, S.P., Zorn, G., Maurer, G., Wagner, O., Huber, K., Minar, E., Wojta, J., and Schillinger, M. (2005) Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosis. Europ. Heart. J. 26, 2294-2299
54. Sinauridze, E.I., Kireev, D.A., Popenko, N.Y., Pichugin, A.V., Panteleev, M.A., Krymskaya, O.V., and Ataullakhanov, F.I. (2007) Platelet microparticle membrane have 50 - 100 fold higher specific procoagulant activity than activated platelets. Thromb Haemost; 97, 425-434
55. Shenghe, C., and Davie III, A.E. (2003) Complement regulatory protein C1 inhibitor binds to selectins and interferes with endothelial-leukocyte adhesion. J. Immunol. 171, 4786- 4791
56. Torzewsjki, J., Bowher, D.E., Wlatenberger, J., and Fitzsimmons, C. (2007) Processes in atherogenesis: complement activation. Atherosclerosis 132,131-138
57. Vaziri-Sani, F., Hellwage, J., Zipfel, P.F., Sjoholm, A.G., Iancu, R., and Karpman, D. (2004) Factor H binds to washed human platelets. J. Thromb. Haemost. 3, 154-162
58. Vermes, I., Haanen, C., Steffen-Nakken, H., and Reutelingsperger, C. (1995) A novel assay of apoptosis : flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein-labeled Annexin V. J. Immunol. Methods 184, 39-51
59. Vlaicu, R., Niculescu, F., Rus, H.G., and Cristea A.(1985) Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque. Atherosclerosis 57, 163-177
60. Wiedmer, T., Esmon, C.T., and Sims, P.J. (1986) Complement proteins C5b-9 stimulate procoagulant activity through platelet prothrombinase. Blood 68, 875-880
61. Yin, W., Ghebrehiwet, B., and Peerschke, E.I.B. (2008) Expression of complemen components and inhibitors on platelet microparticles. Platelets 19, 225-233
62. Zimmerman, T.S., and Kolb, N.P. (1976) Human platelet-initiated formation and uptake of the C5-9 complex of human complement. J. Clin. Invest. 57, 203-211